LEV-102
Acquired blepharoptosis
Phase 1/2Active
Key Facts
About Levation Pharma
A topical, drug‑delivered solution for age‑related eyelid droop, aiming to replace blepharoplasty.
View full company profileTherapeutic Areas
Other Acquired blepharoptosis Drugs
| Drug | Company | Phase |
|---|---|---|
| UPNEEQ® (oxymetazoline) Mini | Santen | Marketed |